Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
- PMID: 33709115
- DOI: 10.1093/eurheartj/ehab081
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
Abstract
Aims: Lipoprotein(a) [Lp(a)] is a recognized causal risk factor for atherosclerotic cardiovascular disease but its role for acute ischaemic stroke (AIS) is controversial. In this study, we evaluated the association of Lp(a) with large artery atherosclerosis (LAA) stroke and risk of recurrent cerebrovascular events in AIS patients.
Methods and results: For this analysis of the prospective, observational, multicentre BIOSIGNAL cohort study we measured Lp(a) levels in plasma samples of 1733 primarily Caucasian (98.6%) AIS patients, collected within 24 h after symptom onset. Primary outcomes were LAA stroke aetiology and recurrent cerebrovascular events (ischaemic stroke or transient ischaemic attack) within 1 year. We showed that Lp(a) levels are independently associated with LAA stroke aetiology [adjusted odds ratio 1.48, 95% confidence interval (CI) 1.14-1.90, per unit log10Lp(a) increase] and identified age as a potent effect modifier (Pinteraction =0.031) of this association. The adjusted odds ratio for LAA stroke in patients aged <60 years was 3.64 (95% CI 1.76-7.52) per unit log10Lp(a) increase and 4.04 (95% CI 1.73-9.43) using the established cut-off ≥100 nmol/l. For 152 recurrent cerebrovascular events, we did not find a significant association in the whole cohort. However, Lp(a) levels ≥100 nmol/l were associated with an increased risk for recurrent events among patients who were either <60 years [adjusted hazard ratio (HR) 2.40, 95% CI 1.05-5.47], had evident LAA stroke aetiology (adjusted HR 2.18, 95% CI 1.08-4.40), or had no known atrial fibrillation (adjusted HR 1.60, 95% CI 1.03-2.48).
Conclusion: Elevated Lp(a) was independently associated with LAA stroke aetiology and risk of recurrent cerebrovascular events among primarily Caucasian individuals aged <60 years or with evident arteriosclerotic disease.
Keywords: Acute ischaemic stroke; Large artery atherosclerosis; Lipoprotein(a).
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Comment in
-
Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.Eur Heart J. 2021 Jun 7;42(22):2197-2200. doi: 10.1093/eurheartj/ehab251. Eur Heart J. 2021. PMID: 34000000 No abstract available.
Similar articles
-
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.J Am Heart Assoc. 2017 Dec 15;6(12):e007372. doi: 10.1161/JAHA.117.007372. J Am Heart Assoc. 2017. PMID: 29246963 Free PMC article. Clinical Trial.
-
Association of modifiable risk factors with ischaemic stroke subtypes in Asian versus Caucasian populations: A systematic review and meta-analysis.Eur J Clin Invest. 2022 Nov;52(11):e13849. doi: 10.1111/eci.13849. Epub 2022 Aug 5. Eur J Clin Invest. 2022. PMID: 35906805 Review.
-
Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.Eur J Prev Cardiol. 2022 Feb 9;28(18):2038-2047. doi: 10.1093/eurjpc/zwab016. Eur J Prev Cardiol. 2022. PMID: 34343284
-
Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.Lancet Neurol. 2023 Apr;22(4):320-329. doi: 10.1016/S1474-4422(23)00067-4. Lancet Neurol. 2023. PMID: 36931807
-
Long-term outcome after ischaemic stroke/transient ischaemic attack.Cerebrovasc Dis. 2003;16 Suppl 1:14-9. doi: 10.1159/000069936. Cerebrovasc Dis. 2003. PMID: 12698014 Review.
Cited by
-
Fibrinogen-to-Albumin Ratio and Clinical Outcomes in Patients With Large Artery Atherosclerosis Stroke.J Am Heart Assoc. 2023 Dec 19;12(24):e030837. doi: 10.1161/JAHA.123.030837. Epub 2023 Dec 8. J Am Heart Assoc. 2023. PMID: 38063159 Free PMC article.
-
Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis.PLoS One. 2023 Nov 20;18(11):e0294250. doi: 10.1371/journal.pone.0294250. eCollection 2023. PLoS One. 2023. PMID: 37983217 Free PMC article.
-
Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke.Eur Stroke J. 2023 Mar;8(1):309-319. doi: 10.1177/23969873221145391. Epub 2022 Dec 21. Eur Stroke J. 2023. PMID: 37021149 Free PMC article.
-
Lipoprotein(a) and residual vascular risk in statin-treated patients with first acute ischemic stroke: A prospective cohort study.Front Neurol. 2022 Nov 3;13:1004264. doi: 10.3389/fneur.2022.1004264. eCollection 2022. Front Neurol. 2022. PMID: 36408516 Free PMC article.
-
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention.Metabolites. 2022 Nov 4;12(11):1065. doi: 10.3390/metabo12111065. Metabolites. 2022. PMID: 36355148 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous

